OOIR: Observatory of International Research

Papers

(The H4-Index of Neoplasia is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Corrigendum to “Tumorigenicity of IL-1α- and IL-1β-Deficient Fibrosarcoma Cells” [Neoplasia, Volume 10, Issue 6, June 2008, Pages 549–562]	1683
DHX34 deficiency triggers tumor-intrinsic immunity via a dsRNA-mediated type I interferon pathway activation in HCC	115
Corrigendum to “Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells” [Neoplasia 17 (2014) 85]	100
The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells	59
ARID1A loss sensitizes colorectal cancer cells to floxuridine	59
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma	55
5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD	53
High metastatic tumor-derived CXCL16 mediates liver colonization metastasis by inducing Kupffer cell polarization via the PI3K/AKT/FOXO3a pathway	53
L-methionine promotes CD8+ T cells killing hepatocellular carcinoma by inhibiting NR1I2/PCSK9 signaling	45
Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene	45
Epitranscriptomic mechanisms of androgen signalling and prostate cancer	45
Single cell analysis unveils the commonality and heterogeneity between nasopharyngeal and oropharyngeal carcinoma	44
Sialylated IgG-activated integrin β4-Src-Erk axis stabilizes c-Myc in a p300 lysine acetyltransferase-dependent manner to promote colorectal cancer liver metastasis	42
Myxoid glioneuronal tumor: Histopathologic, neuroradiologic, and molecular features in a single center series	41
Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer	40
Mutational signatures and their association with survival and gene expression in urological carcinomas	40
Time-restricted feeding affects the fecal microbiome metabolome and its diurnal oscillations in lung cancer mice	39
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy	39
Retraction notice to “Role of Autophagy as a Survival Mechanism for Hypoxic Cells in Tumors” [Neoplasia 18 (2016) 347- 355/201]	38
RUNX2 enhances bladder cancer progression by promoting glutamine metabolism	37
New horizons in B-cell lymphoma immunotherapy: From immune checkpoints to precision medicine	37
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy	34
Tumor-Infiltrating Immune Cells in Colorectal Cancer	33
A spatiotemporal atlas of orchiectomy-induced androgen deprivation-mediated modulation of cellular composition and gene expression in the mouse prostate	31
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations	31

The role of glycolysis in tumorigenesis: From biological aspects to therapeutic opportunities	30
Rezatapopt: A promising small-molecule “refolder” specific for TP53Y220C mutant tumors	29
Advanced progress of spatial metabolomics in head and neck cancer research	28
Identification of recurrent BRAF non-V600 mutations in intraductal carcinoma of the prostate in Chinese populations	28